Biotechnology UltraSector ProFund
Investment Objective
The Biotechnology UltraSector ProFund seeks daily investment results, before fees and expenses, that are 1.5x the return of the Dow Jones U.S. BiotechnologySM Index (the "Index") for a single day.
Documents & Downloads
You may order paper copies by contacting ProFunds Client Services at 866-PRO-5125 (866-776-5125)
About the Fund
Investor Class
- Ticker BIPIX
- CUSIP 743185480
- Fund Number 43
- NAV (as of 2/03/2023) $60.21
- NAV Change $-0.23 ( -0.38%)
Service Class
- Ticker BIPSX
- CUSIP 743185472
- Fund Number 73
- NAV (as of 2/03/2023) $39.94
- NAV Change $-0.15 (-0.38%)
Details
- Inception Date 6/19/2000
- Fund Group UltraSector ProFunds
- Limits on Exchanges None
- Minimum Investment (Individual) $15,000
- Minimum Investment (Financial Professional) $5,000
- Gross Expense Ratio 1.55%
- Net Expense Ratio* 1.55%
Investor Class
- Ticker BIPIX
- CUSIP 743185480
- Fund Number 43
- NAV (as of 2/03/2023) $60.21
- NAV Change $-0.23 (-0.38%)
Service Class
- Ticker BIPSX
- CUSIP 743185472
- Fund Number 73
- NAV (as of 2/03/2023) $39.94
- NAV Change $-0.15 (-0.38%)
Details
- Inception Date 6/19/2000
- Fund Group UltraSector ProFunds
- Limits on Exchanges None
- Minimum Investment (Individual) $15,000
- Minimum Investment (Financial Professional) $5,000
- Gross Expense Ratio 1.55%
- Net Expense Ratio* 1.55%
*Contractual waiver effective from December 1, 2021 through November 30, 2022. Without such a waiver of fees, the total returns may have been lower.
All data, unless otherwise noted, is for Investor Class Shares only and is subject to change.
Performance
Growth of $10,000
Since Inception
For standardized returns year-to-date, and as of the most recent calendar quarter-end, and annualized month-end, see performance. Returns include the reinvestment of dividends and capital gains.
Total Return
| Fund + Index | 1m | 3m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Gross Expense Ratio (%) |
Net Expense Ratio |
Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology UltraSector ProFund | 0.35% | 7.27% | 0.35% | 0.95% | 12.57% | 4.28% | 15.40% | 7.02% | 1.55% | 1.55% | 06/19/2000 |
| Fund + Index | 1m | 3m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Gross Expense Ratio (%) |
Net Expense Ratio |
Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology UltraSector ProFund | -4.56% | 21.71% | -13.43% | -13.43% | 8.78% | 6.92% | 16.59% | 7.03% | 1.55% | 1.55% | 06/19/2000 |
| Fund + Index | 1m | 3m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Gross Expense Ratio (%) |
Net Expense Ratio |
Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology UltraSector ProFund | 0.25% | 7.02% | 0.25% | -0.05% | 11.45% | 3.24% | 14.26% | 5.97% | 2.55% | 2.55% | 06/19/2000 |
| Fund + Index | 1m | 3m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Gross Expense Ratio (%) |
Net Expense Ratio |
Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology UltraSector ProFund | -4.62% | 21.42% | -14.29% | -14.29% | 7.70% | 5.86% | 15.43% | 5.98% | 2.55% | 2.55% | 06/19/2000 |
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost.
Index
as of 12/30/2022
- Total Number of Companies50
- Price/Earnings Ratio24.48
- Price/Book Ratio6.37
- Dividend Yield ( % )1.34
- Avg. Index Market Capitalization$28.91 billion
Dow Jones U.S. Biotechnology Index
The Index (Bloomberg symbol: DJUSBT) measures the performance of the biotechnology sector of the U.S. equity market. Component companies engage in research and development of biological substances for drug discovery and diagnostic development. These companies derive most of their revenue from the sale or licensing of drugs and diagnostic tools. It is not possible to invest directly in an index.
Exposures
Index as of 12/30/2022
Sum of weightings may not equal 100% due to rounding. These percentages are allowed to fluctuate between semi-annual reconstitution dates and may be higher or lower than the indicated amounts until they are reset at the next Index reconstitution date.
Distributions
There is no guarantee that dividends or interest income will be paid.